Adie Viljoen
- Endocrinology, Diabetes and Metabolism top 0.5%
- Molecular Biology top 10%
- Surgery top 5%
- Pharmacology top 1%
- Physiology top 5%
- Co-authors
- Ildiko LingvayAnthony S. WierzbickiRichard E. PratleyVanita R. ArodaJ LüdemannAndrea NavarriaCatharine M. SturgeonSue D. Pedersen
- Topics
- Diabetes Treatment and Management (31 papers)Lipoproteins and Cardiovascular Health (27 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers)
- Journals
- The LancetPLoS ONEDiabetes
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Adie Viljoen
93 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Endocrinology, Diabetes and Metabolism 1.9k
- Molecular Biology 1.1k
- Surgery 873
- Pharmacology 724
- Physiology 507
Countries citing papers authored by Adie Viljoen
This map shows the geographic impact of Adie Viljoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adie Viljoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adie Viljoen more than expected).
Fields of papers citing papers by Adie Viljoen
This network shows the impact of papers produced by Adie Viljoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adie Viljoen. The network helps show where Adie Viljoen may publish in the future.
Co-authorship network of co-authors of Adie Viljoen
This figure shows the co-authorship network connecting the top 25 collaborators of Adie Viljoen. A scholar is included among the top collaborators of Adie Viljoen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adie Viljoen. Adie Viljoen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 9 | |
| 6 | 7 | |
| 7 | 21 | |
| 8 | 17 | |
| 9 | 13 | |
| 10 | 1 | |
| 11 | 37 | |
| 12 | 2 | |
| 13 | 45 | |
| 14 | 8 | |
| 15 | 29 | |
| 16 | 7 | |
| 17 | 29 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 13 |
About Adie Viljoen
Adie Viljoen is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Family Practice, having authored 98 papers that have together received 3.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (31 papers), Lipoproteins and Cardiovascular Health (27 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Pharmacology (724 citations) and Nephrology (191 citations). Adie Viljoen has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ildiko Lingvay, Anthony S. Wierzbicki, Richard E. Pratley, Vanita R. Aroda, J Lüdemann, Andrea Navarria, Catharine M. Sturgeon, Sue D. Pedersen, Iichiro Shimomura and Thomas A. Wadden. Their work appears in journals such as The Lancet, PLoS ONE and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.